Incyte Discloses Promising New Data in Combo Drug Trial With Merck & Co.'s Keytruda Post author:Sam Post published:August 30, 2017 Post category:BioPharma August 31, 2017By Mark Terry… Source: BioSpace You Might Also Like Roche Boss Claims pRED Division Soon to Emerge from Genentech's Shadow December 18, 2017 Phase I Clinical Data Of ABX464, ABIVAX's First-In-Class Anti-HIV Drug, Published In Two Articles In Peer-Reviewed Journals February 2, 2017 A Look at the 5 Most Profitable Biopharma Companies June 19, 2017
Phase I Clinical Data Of ABX464, ABIVAX's First-In-Class Anti-HIV Drug, Published In Two Articles In Peer-Reviewed Journals February 2, 2017
